Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03432819 · ClinicalTrials.gov registry record · NA
A Pilot Intervention to Improve Coping With Discrimination and Adherence Among HIV-Positive Latino MSM
A NA study of HIV, sponsored by RAND.
- Completed
- Registry status
- NA
- Development phase
- 82
- Enrollment target
- 1
- Study location
NCT03432819: Completed NA study of HIV, sponsored by RAND.
NCT03432819 is a NA study of HIV that has completed, run by RAND. The registered enrollment target is 82 participants, below the 440-participant average among 303 other HIV trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03432819, a NA study of HIV, has completed, sponsored by RAND.
- COMPLETED
- Registry status
- NA
- Development phase
- 82 participants
- Enrollment target
- 1
- Study location
Study Summary
R34-funded study to pilot test an intervention to improve coping with discrimination and adherence among Latino men who have sex with men (MSM) living with HIV. The proposed research aims to modify and refine Siempre Seguiré, a culturally congruent cognitive behavior therapy group intervention for HIV-positive Latino men who have sex with men (LMSM), to include strategies for ART adherence and retention in HIV care; and to conduct a small randomized pilot of Siempre Seguiré to examine feasibility and acceptability, as well as to explore preliminary effects on coping responses to discrimination and antiretroviral treatment adherence among LMSM living with HIV.
Primary Outcome
Percentage of doses taken, of those prescribed, from electronic monitoring
Conditions Studied
Interventions
- BEHAVIORAL Siempre Seguiré
Study Locations (1)
California
- Bienestar Human Services, Inc. - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 82 participants |
| Start Date | 2018-03-27 |
| Est. Completion | 2019-09-16 |
| Phase | NA |
What the finished NCT03432819 record still lists
NCT03432819 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 82 participants, a relatively small participant target, below the 440-participant average among 303 other HIV trials with a reported enrollment target (81% lower).
The record links to 1 condition, with HIV appearing as the primary indexed condition, and to 1 intervention - of which Siempre Seguiré is the first listed.
NCT03432819 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03432819 about?
NCT03432819 is a clinical study titled "A Pilot Intervention to Improve Coping With Discrimination and Adherence Among HIV-Positive Latino MSM". R34-funded study to pilot test an intervention to improve coping with discrimination and adherence among Latino men who have sex with men (MSM) living with HIV. The proposed research aims to modify and refine Siempre Seguiré, a culturally congruent cognitive behavior therapy group intervention for H...
What is the current status of trial NCT03432819?
This trial is currently completed. It is a NA study. The enrollment target is 82 participants. The study started on 2018-03-27. Estimated completion is 2019-09-16.
What conditions does trial NCT03432819 study?
This clinical trial studies the following conditions: HIV.
What interventions are being tested in trial NCT03432819?
The interventions under investigation include: Siempre Seguiré (BEHAVIORAL).
Who is sponsoring clinical trial NCT03432819?
This trial is sponsored by RAND, which has 78 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03432819 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03432819's enrollment target sits among peer trials
82 174th of 303 higher than 130 of 303 other HIV trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Text Education About Cardiovascular Health and HIV (TEACH-HIV)
RECRUITING · NA
-
1MoreStep: An Intervention to Increase HIV Care Engagement and Reduce Intimate Partner Violence Among Black Women Living With HIV
RECRUITING · NA
-
Implementation Trial to Evaluate a Population Health Combination Intervention to Meet HIV Testing, Linkage, and Viral Suppression Goals in Alabama
RECRUITING · NA
-
ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services
RECRUITING · NA
-
Assessing Peer Support for Physical Activity in Women With HIV and Hypertension
RECRUITING · NA
-
Open Trial of Trauma-focused Psychodynamic Psychotherapy for People Living With HIV and PTSD
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03319901 · 82 participants · Phase 1
Venetoclax and Chemotherapy as Frontline Therapy in Older Patients and Patients With Relapsed/Refractory ALL
- NCT03493425 · 82 participants · Phase 2
Chemotherapy Before Surgery and Radiation Therapy or Surgery and Radiation Therapy Alone in Treating Patients With Nasal and Paranasal Sinus Cancer That Can Be Removed by Surgery
- NCT04105270 · 82 participants · Phase 2
RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial
- NCT04428658 · 82 participants · NA
Randomized Trial of Supplemental Synchronous and Asynchronous Telehealth to Improve Glycemic Control for Pediatric Patients With Type 1 Diabetes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI